Related Experiment Video
Updated: Aug 19, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
Sizing it up: cellular MRI using micron-sized iron oxide particles
Erik M Shapiro1, Stanko Skrtic, Alan P Koretsky
1Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. ShapiroE@ninds.nih.gov
Abstract:
There is rapidly increasing interest in the use of MRI to track cell migration in intact animals. Currently, cell labeling is usually accomplished by endocytosis of nanometer-sized, dextran-coated iron oxide particles. The limitations of using nanometer-sized particles, however, are that millions of particles are required to achieve sufficient contrast, the label can be diluted beyond observability by cell division, and the label is biodegradable. These problems make it difficult to label cells other than macrophages in vivo, and to conduct long-term engraftment studies. It was recently demonstrated that micron-sized iron oxide particles (MPIOs) can be taken up by a number of cell types. In this study we examined the MRI properties of single MPIOs with sizes of 0.96, 1.63, 2.79, 4.50, and 5.80 microm. Furthermore, the capacity of cells to endocytose these MPIOs was investigated, and the MRI properties of the labeled cells at 7.0 and 11.7 Tesla were measured as a function of image resolution and echo time (TE). Cells labeled with MPIOs generally contained iron levels of approximately 100 pg, which is approximately threefold higher than those obtained with the best strategies to label cells using nanometer-sized particles. On occasion, some cells had levels as high as approximately 400 pg. We demonstrate that these large particles and the cells labeled with them can be detected by spin echo (SE)-based imaging methods. These measurements indicate that MPIOs should be useful for improving cell tracking by MRI.
Insights
Micron-sized iron oxide particles (MPIOs) offer improved MRI contrast for cell tracking compared to nanometer-sized particles. MPIOs enable higher iron uptake by cells, facilitating better detection and long-term tracking in vivo.
Area of Science:
- Biomedical Imaging
- Nanotechnology
- Cell Biology
Background:
- Magnetic Resonance Imaging (MRI) is increasingly used for in vivo cell tracking.
- Current cell labeling methods using nanometer-sized iron oxide particles have limitations, including low contrast, dilution with cell division, and biodegradability.
- These limitations hinder tracking of non-macrophage cells and long-term studies.
Purpose of the Study:
- To investigate the MRI properties of micron-sized iron oxide particles (MPIOs).
- To assess the capacity of various cell types to endocytose MPIOs.
- To evaluate the MRI detectability of MPIO-labeled cells at different magnetic field strengths and imaging parameters.
Main Methods:
- Examined MRI properties of single MPIOs across a range of sizes (0.96–5.80 microm).
- Investigated cellular uptake of MPIOs via endocytosis.
- Measured MRI properties of MPIO-labeled cells at 7.0 and 11.7 Tesla, varying image resolution and echo time (TE).
Main Results:
- MPIO-labeled cells achieved approximately threefold higher iron content (~100 pg) compared to nanoparticle labeling.
- Some cells exhibited iron levels as high as ~400 pg.
- Spin echo (SE)-based imaging successfully detected MPIOs and labeled cells.
Conclusions:
- MPIOs provide significantly enhanced MRI contrast for cell labeling.
- MPIOs overcome limitations of nanoparticle-based cell tracking, enabling higher iron loading.
- MPIOs show promise for improving in vivo cell tracking accuracy and duration.

